- Home
- PPTA vs WGS Comparison
PPTA vs WGS Comparison
Compare PPTA & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPTA
- WGS
- Stock Information
- Founded
- PPTA 2011
- WGS 2017
- Country
- PPTA United States
- WGS United States
- Employees
- PPTA N/A
- WGS N/A
- Industry
- PPTA Precious Metals
- WGS Retail: Computer Software & Peripheral Equipment
- Sector
- PPTA Basic Materials
- WGS Technology
- Exchange
- PPTA Nasdaq
- WGS Nasdaq
- Market Cap
- PPTA 2.9B
- WGS 2.4B
- IPO Year
- PPTA N/A
- WGS N/A
- Fundamental
- Price
- PPTA $25.01
- WGS $166.40
- Analyst Decision
- PPTA Strong Buy
- WGS Strong Buy
- Analyst Count
- PPTA 4
- WGS 8
- Target Price
- PPTA $25.38
- WGS $130.63
- AVG Volume (30 Days)
- PPTA 3.0M
- WGS 536.5K
- Earning Date
- PPTA 11-17-2025
- WGS 10-28-2025
- Dividend Yield
- PPTA N/A
- WGS N/A
- EPS Growth
- PPTA N/A
- WGS N/A
- EPS
- PPTA N/A
- WGS 0.07
- Revenue
- PPTA N/A
- WGS $402,190,000.00
- Revenue This Year
- PPTA N/A
- WGS $39.54
- Revenue Next Year
- PPTA N/A
- WGS $22.50
- P/E Ratio
- PPTA N/A
- WGS $2,298.07
- Revenue Growth
- PPTA N/A
- WGS 50.50
- 52 Week Low
- PPTA $7.81
- WGS $55.17
- 52 Week High
- PPTA $31.65
- WGS $170.75
- Technical
- Relative Strength Index (RSI)
- PPTA 58.45
- WGS 74.87
- Support Level
- PPTA $21.00
- WGS $119.43
- Resistance Level
- PPTA $25.24
- WGS $147.71
- Average True Range (ATR)
- PPTA 1.67
- WGS 9.54
- MACD
- PPTA 0.19
- WGS 3.23
- Stochastic Oscillator
- PPTA 94.86
- WGS 92.28
About PPTA Perpetua Resources Corp.
Perpetua Resources Corp is focused on the exploration, site restoration, and redevelopment of gold-antimony-silver deposits in the Stibnite-Yellow Pine district of central Idaho that are encompassed by the Stibnite Gold Project. The Project is one of the highest-grade, open-pit gold deposits in the United States and is designed to apply a modern, responsible mining approach to restore an abandoned mine site and produce both gold and the only mined source of antimony in the United States. It has one segment, mineral exploration in the United States.
About WGS GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.